用于分子生态学研究的堆肥DNA提取方法

分子生态学为堆肥微生物的研究提供了新的技术手段,DNA的提取是该技术的基础,但由于腐殖酸类物质的污染,增加了堆肥微生物总DNA的提取难度.采用了3种不同的方法(溶菌酶法、超声波破碎法和蛋白酶K-CTAB法)从堆肥中提取微生物的总DNA,使用核酸和蛋白质分析仪检测后表明3种提取方法获得的DNA产量均较高;琼脂糖凝胶电泳结果表明其长度约为23 kb;使用细菌16S rRNA基因通用引物(27F和1 495R)对总DNA进行PCR扩增,都获得了几乎全长的16S rDNA序列(约1.5 kb);利用限制性内切酶(Hae Ⅲ和AluⅠ)对纯化后的PCR产物进行RFLP分析,结果表明3种方法提取的DNA反映了比较一致的微生物多样性.虽然3种方法各有优缺点,但其提取的DNA都可以用于堆肥微生物的分子生态学研究,可以根据实际需要选用某一种方法用于提取堆肥总DNA.     

Extraction of DNA from amniotic fluid cells for the early prenatal diagnosis of genetic disease

Ten-ml samples of amniotic fluid were taken from pregnancies being terminated at 8–14 weeks' gestation. DNA was extracted from the amniotic cells by sequential centrifugation and analysed using the polymerase chain reaction (PCR). Fifteen samples were analysed for evidence of maternal contamination using Mfd5 oligo-nucleotide primers for repeat polymorphisms. Ten amniotic fluid samples were tested for the Delta-F₅₀₈ deletion characteristic of cystic fibrosis to demonstrate a diagnostic application for the technique. In each case, DNA extracted from fetal tissue from the same pregnancy was included in the controls. In 14 of the 15 cases tested with the Mfd5 primers, both the amniotic fluid DNA and the fetal DNA showed no evidence of contaminating DNA. In one case, neither the amniotic fluid cells nor the fetal cells yielded results. In nine of the ten cases tested with the Delta-F₅₀₈ primers, the amniotic fluid cell DNA provided accurate information about the genetic status of the fetus; in the tenth, the fetal DNA failed to amplify. The results indicate that adequate DNA can be extracted from amniotic fluid from 8 weeks' gestation onward and these samples are suitable for prenatal diagnosis using PCR.     

固态发酵过程中微生物总DNA提取方法比较

为了分析固态发酵过程中微生物群落的多样性及演替情况,对比研究了从固态发酵中提取细菌和真菌DNA的3种方法--溶壁酶法、超声波法、液氮研磨 CTAB法.使用紫外分光光度计测定了由不同提取方法得到的DNA的产量与纯度;使用细菌16S rDNA基因通用引物(341F和907R)和真菌18S rDNA基因通用引物(NU-SSU-0817和NU-SSU-119)对DNA进行了PCR扩增;采用DGGE(变性梯度凝胶电泳)法对固态发酵中细菌和真菌的多样性进行了分析.结果显示,3种方法得到的粗提和纯化DNA长度均约为23 kb;细菌和真菌PCR产物长度分别约为586 bp和422 bp.细菌和真菌PCR产物的DGGE分析表明,3种方法提取的DNA所反映的微生物多样性比较一致;但紫外分光光度计测定结果表明溶壁酶法提取固态发酵中微生物总DNA产量最高,超声波法次之,液氮研磨 CTAB法最低.     

金鱼组织中壬基酚的含量检测新方法探讨

建立一种直接检测环境中痕量壬基酚的外切酶保护-荧光定量PCR方法。首先向含雌激素受体及相关蛋白的细胞溶质中加入壬基酚-丙酮溶液,使受体蛋白活化,从而在体外与含雌激素反应位点的双链结合DNA作用形成壬基酚-雌激素受体-DNA复合物。复合物用核酸外切酶和S1核酸酶消解,去除未受到蛋白质保护的结合DNA。将消解后产物作为模板,进行荧光定量PCR扩增反应,建立壬基酚浓度与标准DNA拷贝数的对数之间的线性关系为：y（壬基酚浓度的对数）=1.637x（标准DNA拷贝数的对数）-9.505。该法检出限为10^-8g/L,用该法对金鱼肝脏组织中壬基酚进行检测,添加回收率水平在98.5%112.2%,变异系数在4.3%以下。     

一种高效提取焦化废水活性污泥总DNA的方法

对焦化废水活性污泥中微生物建立高质量的总DNA提取方法是开展分子生态学研究的重要前提.通过反复冻融-蛋白酶K-SDS、溶菌酶-反复冻融-SDS及溶菌酶-反复冻融-蛋白酶K-SDS这3种综合方法对焦化废水活性污泥总DNA进行提取,以OD260/OD280、OD260/OD230、产率、片段完整性、片段大小5个指标来评价样品总DNA的提取效果.结果表明,溶菌酶-反复冻融-蛋白酶K-SDS法所提取的总DNA的OD260/OD280值约为1.8,产率为1.90～16.30 μg·g-1,片断完整性好,主带清晰,大小约为23 kb,其PCR反应抑制物少,能够直接进行16S rRNA基因的PCR扩增.溶菌酶-反复冻融-蛋白酶K-SDS法能够为焦化废水活性污泥中微生物的分子生态学研究提供高质量的总DNA.     

大气飘尘致癌物与DNA加合物的^32P后标记分析

采用~(32)P后标记分析法,测定上海市大气飘尘中致癌物与DNA形成加合物的能力。先将飘尘行机提取物,按一定剂量涂抹到小鼠皮肤上作用一定时间;然后,处死小鼠,取涂抹部位皮肤提取DNA,用~(32)P后标记法分离测定DNA中致癌物,即DNA加合物。结果表明,上海市大气飘尘有机提取物可以与皮肤DNA形成多个加合物斑点,提示上海市大气飘尘存在一定的致癌危险性。     

一种简便快速检测涕灭威对DNA损伤的方法

介绍一种简便、快速检测涕灭威对DNA损伤的方法,并将这种方法与其他几种检测DNA损伤的方法进行了比较.这种方法直接把菌体或组织匀浆液放入琼脂糖凝胶的加样孔穴中,在原位裂解后,在较高pH环境下进行电泳,根据DNA的量和损伤程度评价涕灭威对生物个体或生态系统产生的影响.     

An E. coli SOS-EGFP biosensor for fast and sensitive detection of DNA damaging agents

An E. coli SOS-EGFP biosensor which expresses enhanced green fluorescent protein as a reporter protein under the control of recA gene promoter in SOS response was constructed for detection of DNA damage and evaluation of DNA damaging chemicals. The chemicals that may cause substantial DNA damage will trigger SOS response in the constructed bacterial biosensor, and then the reporter egfp gene under the control of recA promoter is stimulated to express as a fluorescent protein, allowing fast and sensitive fluorescence detection. Interestingly, this biosensor can be simultaneously applied for evaluation of genotoxicity and cytotoxicity. The SOS-EGFP bacterial biosensor provides a sensitive, specific and simple method for detecting known and potential DNA damaging chemicals.     

DNA Heat Treatment for Improving qPCR Analysis of Human Adenovirus in Wastewater

PCR inhibitory substances in complex sample matrices can cause false negatives or under-estimation of target concentration. This study assessed DNA heat treatment for reducing inhibition during qPCR analysis of human adenovirus (HAdV) in wastewater samples. Inhibition was reduced by heat treating DNA, where mean HAdV concentration was increased by 0.71 log₁₀ GC/L (and up to 3.04 log₁₀ GC/L in one case), and replicate variability and false negatives were reduced. DNA heat treatment should be further investigated for improving reliability of HAdV concentration estimates in water, which can support more accurate assessment of health risks associated with viral pathogen exposure.     

Chemical carcinogenesis — the price for DNA-repair?

This essay examines the possibility of merging the mutation theory of cancer with the hypothesis that cancer is a change in the state of the differentiation of cells. It is suggested that during normal development DNA rearrangements occur, concerning genes which code for differentiation specific cell communication proteins. These proteins are responsible for the proper functioning of growth control in a multicellular organism. DNA-damaging agents — mutagens — induce DNA repair enzymes, some of which may catalyse illegitimate genome rearrangements, thus leading to a change of the balance between growth and differentiation. A cell with a selective advantage may arise and become the origin of a tumor.     

生物硝化池污水中硝化细菌的快速定量研究

实验采用聚合酶链式反应（PCR）技术与最大几率数法（MPN）相结合的MPN－PCR法对生物硝化池污水中的硝化细菌进行快速定量。所用的一对PCR引物是在对硝化细菌的16SrRNA基因进行系统比较的基础上设计合成的，可以扩增出大小为388bp的DNA片段。以从生物硝化池污水中抽提的含硝化细菌DNA的混合DNA为模板，进行PCR扩增并确定合适的扩增条件。运用MPN－PCR法进行定量检测的整个过程可在几小时之内完成。     

质谱法定量生态物种基因组DNA低甲基化

为了定量生态相关物种基因组中低丰度的5-甲基-2-脱氧胞苷(5-mdC),建立了一种采用高效液相色谱串联质谱(HPLC-MS/MS)的无标记方法.全基因组DNA甲基化计算公式5-mdC (mole)/(5-mdC (mole)+dC (mole)可以转化为1/(1+dC (mole)/5-mdC (mole)),然后通过HPLC-MS/MS得到DNA样品中5-mdC和dC的物质的量比(dC (mole)/5-mdC (mole))即可得到基因组DNA甲基化值.此外,还对HPLC条件进行了优化使正常核苷和修饰核苷基线分离,消除分析物的交叉干扰.本方法避免了使用昂贵的稳定同位素标记内标,在等度高效液相色谱条件下实现了正常和修饰核苷基线分离,5-mdC和dC的保留时间分别为5.50和3.06min.5-mdC和dC的定量限分别为14.2和19.1pg/mL.日内和日间偏差和准确性(相对误差)都≤ 10%.该方法测定的小牛胸腺DNA和大型蚤及秀丽线虫的全基因组DNA甲基化值分别为(6.44 ±0.25)%,(0.097 ±0.010)%和(0.025 ±0.002)%.采用HPLC-MS/MS技术建立并验证了一种快速、高精密度和灵敏度的DNA样品全基因组DNA甲基化测定方法,适用于评估环境污染物对生态学相关物种的潜在表观遗传风险.     

长江中下游环境DNA宏条形码生物多样性检测技术初步研究

长江生物多样性在人为影响下面临严重威胁,物种监测是生物多样性保护的基础,为完善长江水生态监测体系,实现高效无损伤的物种监测,在长江中下游干流3个江段（新滩、安庆和芜湖）采集水样,建立长江水样环境DNA宏条形码物种检测体系并评估其有效性.结果表明:①长江中下游环境DNA宏条形码检测到32个物种,包括20种鱼类、1种水生哺乳动物（长江江豚）和11种陆生动物,其中鱼类物种包括鲤形目、鲇形目、鲈形目和鲱形目,其种数占鱼类总种数的比例分别为60%、25%、10%和5%.②长江中下游渔获物中资源量居首位的鲤形目在环境DNA调查中序列数最多,占鱼类总序列的96.2%,其次为鲱形目（占比为3.5%）,鲇形目和鲈形目占比较低,分别为0.2%和0.1%,4个类目序列相对丰度与渔获物种资源量组成差异较大.③环境DNA调查次数约占传统渔获物调查次数的几十至几百分之一,采样时间不足努力量最少的渔获物调查的1%,检测到的鱼类种数为传统调查总数的31%~49%.④安庆采样点位于长江中下游长江江豚密度最高的江段,其环境DNA检出率和序列相对丰度在3个采样点中均最高.研究显示:长江水样环境DNA包含水陆复合生态系统的生物多样性信息,利用水样环境DNA宏条形码可检测不同类群的水生和陆生物种;对于鱼类物种检测,环境DNA宏条形码比传统调查方法效率更高,可对传统调查结果进行补充;环境DNA宏条形码生物多样性检测主要受分子标记体系和核酸序列数据库限制,获取全面的物种多样性和资源量信息需要对检测分析方法进行进一步完善.      

Benefits and limitations of prenatal screening for Prader–Willi syndrome

This review summarizes the status of genetic laboratory testing in Prader–Willi syndrome (PWS) with different genetic subtypes, most often a paternally derived 15q11–q13 deletion and discusses benefits and limitations related to prenatal screening. Medical literature was searched for prenatal screening and genetic laboratory testing methods in use or under development and discussed in relationship to PWS. Genetic testing includes six established laboratory diagnostic approaches for PWS with direct application to prenatal screening. Ultrasonographic, obstetric and cytogenetic reports were summarized in relationship to the cause of PWS and identification of specific genetic subtypes including maternal disomy 15. Advances in genetic technology were described for diagnosing PWS specifically DNA methylation and high-resolution chromosomal SNP microarrays as current tools for genetic screening and incorporating next generation DNA sequencing for noninvasive prenatal testing (NIPT) using cell-free fetal DNA. Positive experiences are reported with NIPT for detection of numerical chromosomal problems (aneuploidies) but not for structural problems (microdeletions). These reports will be discussed along with future directions for genetic screening of PWS. In summary, this review describes and discusses the status of established and ongoing genetic testing options for PWS applicable in prenatal screening including NIPT and future directions for early diagnosis in PWS. © 2016 John Wiley & Sons, Ltd.     

Prenatal diagnosis for dystrophia myotonica using the polymerase chain reaction

The polymerase chain reaction has been used to detect an abundant class of short repeat DNA families of the form (dC-dA)n.(dG-dT)n, known as microsatellites. These units are found throughout the human genome and have been characterized for several loci including APOC2 on chromosome 19ql2-ql3.2. The locus APOC2 is linked to the gene for dystrophia myotonica and a microsatellite within this locus was used to derive polymorphisms in a family to predict the inheritance of the disease. Chorionic villus sampling (CVS) was performed at 151/2 weeks' gestation. Following DNA extraction from the CVS material and parental blood samples, microsatellite analysis was carried out by the polymerase chain reaction.     

Whole genome amplification from a single cell: a new era for preimplantation genetic diagnosis

Preimplantation genetic diagnosis (PGD) is a technique used for determining the genetic status of a single cell biopsied from embryos or oocytes. Genetic analysis from a single cell is both rewarding and challenging, especially in PGD. The starting material is very limited and not replaceable, and the diagnosis has to be made in a very short time. Different whole genome amplification (WGA) techniques have been developed to specifically increase the DNA quantities originating from clinical samples with limited DNA contents. In this review, currently available WGA techniques are introduced and, among them, multiple displacement amplification (MDA) is discussed in detail. MDA generates abundant assay-ready DNA to perform broad panels of genetic assays through its ability to rapidly amplify genomes from single cells. The utilization of MDA for single-cell molecular analysis is expanding at a high rate, and MDA is expected to soon become an integral part of PGD. Copyright © 2007 John Wiley & Sons, Ltd.     

Infantile hypophosphatasia: Successful prenatal assessment by testing for tissue-non-specific alkaline phosphatase isoenzyme gene mutations

We successfully assessed a fetus at risk for lethal infantile hypophosphatasia using amniocyte DNA and allele-specific oligonucleotide (ASO) probes for two missense mutations in the tissue-non-specific alkaline phosphatase isoenzyme (TNSALP) gene. The nucleotide changes had been discovered in a sister who died at 8 months of age from this inborn error of metabolism. The mother was known to carry the 747 (cDNA) G→A transition, whereas her husband and 5-year-old daughter, who were also healthy, carried the 1309 A→T transversion. Amniocytes, obtained at 16 weeks' gestation, provided genomic DNA for polymerase chain reaction (PCR) amplification of the appropriate TNSALP gene exons. ASO hybridization revealed absence of the 747A mutation and presence of the 1309T base change in the fetus, indicating a carrier for hypophosphatasia. At 8 months of age, the offspring was in excellent health and without any radiological evidence of skeletal disease. His serum ALP activity and plasma pyridoxal 5′-phosphate level were decreased and increased, respectively, at levels consistent with the prenatal assessment. The ASO studies were confirmed postnatally using peripheral blood leukocyte DNA. This is the first application of direct mutational analysis to assess a fetus at risk for hypophosphatasia.     

Modulation of the DNA repair system and ATR-p53 mediated apoptosis is relevant for tributyltininduced genotoxic effects in human hepatoma G2 cells

The toxic effects of tributyltin (TBT) have been extensively documented in several types of cells, but the molecular mechanisms related to the genotoxic effects of TBT have still not been fully elucidated. Our study showed that exposure of human hepatoma G2 cells to 1-4 μmol/L TBT for 3 hr caused severe DNA damage in a concentration-dependent manner. Moreover, the expression levels of key DNA damage sensor genes such as the replication factor C, proliferating cell nuclear antigen and poly (ADP-ribose) polymerase-1 were inhabited in a concentration-dependent manner. We further demonstrated that TBT induced cell apoptosis via the p53-mediated pathway, which was most likely activated by the ataxia telangiectasia mutated and rad-3 related (ATR) protein kinase. The results also showed that cytochrome c, caspase-3, caspase-8, caspase-9, and the B-cell lymphoma 2 were involved in this process. Taken together, we demonstrated for the first time that the inhibition of the DNA repair system might be more responsible for TBT-induced genotoxic effects in cells. Then the generated DNA damage induced by TBT initiated ATR-p53-mediated apoptosis.     

False non-paternity in a family for prenatal diagnosis of β-thalassaemia

Initial screening for the common β-thalassaemia mutations with allele-specific oligonucleo-tide probes in an at-risk family suggested non-paternity. Subsequent DNA fingerprinting of the members proved otherwise. The mother had a codon 41/42 frameshift mutation and the father's defect, determined by direct sequencing of PCR-amplified β gene, was a codon 43 nonsense mutation. In the affected children, the close proximity of these two defects resulted in the absence of a hybridization signal to the normal probe in that region and a wrong assumption of homozygosity for the codon 41/42 mutation. The non-reactivity of the father's amplified DNA to the codon 41/42 thalassaemic probe accounted for the initial wrong conclusion of non-paternity. Since prior screening for β-thalassaemia mutations is done in all prenatal diagnosis programmes and concomitant inheritance of these two defects is relatively common in the Chinese, this ‘artefact’ of false non-paternity is worth noting.     

The benefits and limitations of cell-free DNA screening for 22q11.2 deletion syndrome

Cell-free DNA testing is increasingly being used to screen pregnant women for fetal aneuploidy. This technology may also identify microdeletion syndromes, including 22q11.2 deletion syndrome, the most common microdeletion syndrome, and the 22q11.2 duplication syndrome. The purpose of this paper is to provide an overview of the 22q11.2 deletion syndrome, to review the early experience with cell-free DNA screening for this deletion and to consider the potential benefits that may be associated with prenatal detection of the deletion. © 2016 John Wiley & Sons, Ltd.